Cyp4f16 Inhibitors
Cyp4f16 inhibitors are a specialized class of chemical compounds designed to selectively target and inhibit the activity of the Cyp4f16 enzyme, which is a member of the cytochrome P450 superfamily. The Cyp4f16 enzyme is primarily involved in the oxidative metabolism of a variety of lipophilic substrates, including long-chain fatty acids, eicosanoids, and other bioactive lipid molecules. One of the key functions of Cyp4f16 is the hydroxylation of these substrates, a biochemical process that introduces an oxygen atom into the lipid molecule, thereby increasing its solubility and facilitating its further metabolism or excretion. The enzyme's activity plays a critical role in the regulation of lipid signaling pathways, which are essential for maintaining cellular homeostasis, modulating inflammatory responses, and regulating vascular tone. Cyp4f16 is predominantly expressed in tissues such as the liver and kidneys, where it contributes to the metabolism and clearance of bioactive lipids and other endogenous compounds.
Inhibitors of Cyp4f16 are typically small molecules designed to bind specifically to the active site of the enzyme, blocking its ability to catalyze the hydroxylation of its substrates. These inhibitors may function by occupying the enzyme's substrate-binding pocket, effectively preventing access of the natural substrates to the catalytic site, or by inducing conformational changes that reduce the enzyme's catalytic efficiency. The development of Cyp4f16 inhibitors involves detailed structural analysis of the enzyme, focusing on the regions critical for substrate recognition and catalytic activity. By inhibiting Cyp4f16, researchers can explore the enzyme's specific role in lipid metabolism and its broader impact on related metabolic pathways, particularly those involving the synthesis and degradation of bioactive lipids. The study of Cyp4f16 inhibitors is crucial for understanding the enzyme's substrate specificity, its interactions with other enzymes in the lipid metabolism network, and its overall contribution to maintaining the balance of lipid signaling and metabolism within the body. This research deepens our understanding of the functional diversity of cytochrome P450 enzymes and underscores their importance in regulating complex biochemical processes essential for cellular function and systemic health.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
4-Methylumbelliferone | 90-33-5 | sc-206910 sc-206910A sc-206910B sc-206910C sc-206910D | 25 g 100 g 250 g 1 kg 2.5 kg | $35.00 $56.00 $141.00 $431.00 $973.00 | 2 | |
4-Methylumbelliferone indirectly inhibits Cyp4f16 by altering the expression of key genes in the xenobiotic metabolism pathway. This chemical interferes with the enzyme's substrate availability, impeding its catalytic activity. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $42.00 $57.00 | 6 | |
Clotrimazole acts as a direct inhibitor of Cyp4f16 by binding to its heme group, disrupting the enzyme's catalytic function in the metabolism of fatty acids. This leads to a specific inhibition of the target protein. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole serves as a direct inhibitor of Cyp4f16, interfering with its heme group and thereby suppressing its role in the metabolism of arachidonic acid. This results in a targeted inhibition of the protein. | ||||||
Terbinafine | 91161-71-6 | sc-338609 | 100 mg | $560.00 | 1 | |
Terbinafine serves as a direct inhibitor of Cyp4f16, disrupting the enzyme's heme group and impeding its catalytic activity in the metabolism of arachidonic acid. This leads to a specific inhibition of the target protein. | ||||||
Miconazole | 22916-47-8 | sc-204806 sc-204806A | 1 g 5 g | $66.00 $160.00 | 2 | |
Miconazole functions as a direct inhibitor of Cyp4f16, binding to its heme group and interfering with the enzyme's catalytic function in the metabolism of fatty acids. This results in a targeted inhibition of the protein. | ||||||
Fluconazole | 86386-73-4 | sc-205698 sc-205698A | 500 mg 1 g | $54.00 $84.00 | 14 | |
Fluconazole serves as a direct inhibitor of Cyp4f16 by disrupting the enzyme's heme group, hindering its catalytic activity in the metabolism of arachidonic acid. This leads to a specific inhibition of the target protein. | ||||||
Imidazole | 288-32-4 | sc-204776 sc-204776A sc-204776B sc-204776C | 25 g 100 g 1 kg 5 kg | $27.00 $56.00 $84.00 $343.00 | 2 | |
Imidazole acts as an indirect inhibitor of Cyp4f16 by influencing the PI3K/Akt signaling pathway. Through this modulation, the chemical disrupts the cellular processes that regulate the protein's activity. | ||||||
Econazole | 27220-47-9 | sc-279013 | 5 g | $240.00 | ||
Econazole functions as a direct inhibitor of Cyp4f16, binding to its heme group and interfering with the enzyme's catalytic function in the metabolism of fatty acids. This results in a targeted inhibition of the protein. | ||||||